Search results
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 1 day agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Earnings call: BioAtla reports promising data in cancer drug trials By Investing.com
Investing.com· 6 days agoBioAtla's cash reserves are expected to support operations well into the second half of 2025, with a...
Unlocking the body's defenses: Understanding immunotherapy
Medical Xpress· 3 days agoScientists are harnessing the power of the body's natural defense mechanism to develop...
Patients Benefit From Advances at Miami Cancer Institute’s Abbhi Family Bladder Cancer Clinic
Miami Herald via Yahoo News· 2 days ago“It’s an evolving technology, and there will be more we can do in the future,” said Dr. Manoharan....
Gut bacteria enhance cancer immunotherapy in mouse study
Medical Xpress· 4 days agoNow, researchers at Washington University School of Medicine in St. Louis have found, in mice, that...
Earnings call: MiNK Therapeutics advances in cancer therapy programs By Investing.com
Investing.com· 7 days agoMiNK Therapeutics, a pioneering company in cancer and immune-mediated disease treatment, has...
Earnings call: AIM ImmunoTech highlights Q1 2024 progress on cancer trials
Investing.com· 5 days agoAIM ImmunoTech (NYSE: AIM ) Inc. (NYSE American: AIM) provided an optimistic update during its first...
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 1 day agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast...
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
GenomeWeb News· 5 days agoThe partners will employ Oxford BioDynamics' EpiSwitch, a 3D genomics platform based on qPCR that has been used to identify biomarkers of response to immune checkpoint < ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 hours agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung